Mechanical stretch and angiotensin II increase interleukin-13 production and interleukin-13 receptor α2 expression in rat neonatal cardiomyocytes

Circulation Journal

Volumn 72, Issue 4, 2008, Pages 647-653

  Nishimura, Yuki ^a   Inoue, Teruo ^a   Morooka, Toshifumi ^a   Node, Koichi ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

Angiotensin II; Chronic heart failure; Interleukin 13; Interleukin 13 receptor 2; Mechanical stretch

Indexed keywords

ANGIOTENSIN II; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR ALPHA2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; CYTOKINE RELEASE; HEART MUSCLE CELL; IMMUNOHISTOCHEMISTRY; MECHANICAL STRESS; MUSCLE HYPERTROPHY; NEWBORN; NONHUMAN; PARACRINE SIGNALING; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; RNA INTERFERENCE;

ANGIOTENSIN II; ANIMALS; ANIMALS, NEWBORN; BASE SEQUENCE; CELLS, CULTURED; DNA PRIMERS; HEART FAILURE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-13; INTERLEUKIN-13 RECEPTOR ALPHA2 SUBUNIT; MYOCYTES, CARDIAC; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STRESS, MECHANICAL; UP-REGULATION;

EID: 43549109424     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.72.647     Document Type: Article

References (37)

1. Diez J, Gonzalez A, Lopez B, Querejeta R. Mechanisms of disease: Pathologic structural remodeling is more than adaptive hypertrophy in hypertensive heart disease. Nat Clin Pract Cardiovasc Med 2005; 2: 209-216.
2. Grossman W, Jones D, McLaurin LP. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 1975; 56: 56-64.
3. Sadoshima J, Izumo S. The cellular and molecular response of cardiac myocytes to mechanical stress. Ann Rev Physiol 1997; 59: 551-571.
4. Palmieri EA, Benincasa G, Di Rella F, Casaburi C, Monti MG, De Simone G, et al. Differential expression of TNE-alpha, IL-6, and IGF-1 by graded mechanical stress in normal rat myocardium. Am J Physiol 2002; 282: H926-H934.
5. Sumanth DP. Cytokine-induced modulation of cardiac function. Circ Res 2004; 95: 1140-1153.
6. Sun M, Chen M, Dawood F, Zurawska U, Li JY, Parker T, et al. Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state. Circulation 2007; 115: 1398-1407.
7. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circurating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 323: 236-241.
8. Minty A, Chalon P, Derocq JM, Dumont X, Guillemot JC, Kaghad M. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993; 362: 248-250.
9. Holt PG, Macaubas C, Stumbles PA, Sly PD. The role of allergy in the development of asthma. Nature 1999; 402: 12-17.
10. Miloux B, Laurent P, Bonnin O, Lupker J, Caput D, Vita N. Cloning of the human IL-13Rα1 chain and reconstitution with the IL-4Rα of a functional JL-4/IL-13 receptor complex. FEBS Lett 1997; 401: 163-166.
11. Bernard J, Treton D, Vermot DC, Boden C, Horellou P, Angevin E, et al. Expression of Interleukin 13 Receptor in Glioma and Renal Cell Carcinoma: IL13Rα2 as a Decoy Receptor for IL13. Lab Invest 2001; 81: 1223-1231.
12. Hershey GKK. IL-13 receptors and signaling pathways: And evolving web. J Allergy Clin Immunol 2003; 111: 677-690.
13. Yasunaga S, Yuyama N, Arima K, Tanaka H, Toda S, Maeda M. The negative-feedback regulation of the IL-13 signal by the IL-13 receptor alpha2 chain in bronchial epithelial cells. Cytokine 2003; 24: 293-303.
14. Wood N, Whitters MJ, Jacobson BA, Witek J, Sypec JP, Kasaian M, et al. Enhanced interleukin (IL)-13 responses in mice lacking IL-13 receptor alpha 2. J Exp Med 2003; 197: 703-709.
15. Marsha WK, Jackie L, Xueying X, Brian S, Tamlyn YN, Christopher LK. Intedeukin-13: Central mediator of allergic asthma. Science 1998; 282: 2258-2261.
16. Margaret M, Mentink K, Thomas AW. Opposing roles for IL-13 and IL-13 receptor α2 in health and disease. Immunological Reviews 2004; 202: 191-202.
17. Murata T, Obiri NI, Debinski W, Purr RK. Structure of IL-13 receptor: Analysis of subunit composition in cancer and immune cells. Biochem Biophys Res Commun 1997; 238: 90-94.
18. Mentink-Kane MM, Cheever AW, Thompson RW, Hari DM, Kabatereine NB, Vennervald BJ, et al. IL-13 receptor alpha 2 down-modulates granulomatous inflammation and prolongs host survival in schistosomiasis. Proc Natl Acad Sci USA 2004; 101: 586-590.
19. Saito M, Murata T, Watanabe K, Kawakami K, Suzuki M, Koji T, et al. Adenoviral vector-mediated gene transfer of IL-13Ralpha2 chain followed by IL-13 cytotoxin treatment offers potent targeted therapy for cytotoxin-resistant cancers. Int J Cancer 2005; 116: 1-8.
20. Kawakami K, Kioi M, Liu Q, Kawakami M, Puri RK. Evidence that IL-13R alpha2 chain in human glioma cells is responsible for the anti-tumor activity mediated by receptor-directed cytotoxin therapy. J Immunother 2005; 28: 193-202.
21. Nishimura Y, Inoue T, Nitto T, Morooka T, Node K. Increased Interleukin-13 Levels in Patients with Chronic Heart Failure. Int J Cardiology 2007 Nov 19; [Epub ahead of print].
22. Sadoshima J, Jahn L, Takahashi T, Kulik TJ, Izumo S. Molecular Characterization of the Stretch-induced Adaptation of Cultured Cardiac Cells. J Biol Chem 1992; 267: 10551-11560.
23. Komuro I, Kaida T, Shibazaki Y, Kurabayashi M, Takaku F, Yazaki Y. Stretching cardiac myocytes stimulates proto-oncogene expression. J Biol Chem 1990; 265: 3595-3598.
24. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1995; 93: 841-842.
25. Arima K, Ueshima-Suyama R, Sakata Y, Akaiwa M, Mao XQ, Enomoto T. Upregulation of IL-13 concentration in vivo by the IL13 variant associated with bronchial asthma. J Allergy Clin Immunol 2002; 109: 980-987.
26. Arima K, Sato K, Tanaka G, Kanaji S, Terada T, Honjo E. Characterization of the Interaction between Interleukin-13 and Intereukin-13 receptors. J Biol Chem 2005; 280: 24915-24922.
27. Ohtsuka T, Inoue K, Hara Y, Moriaka N, Ohshima K, Suzuki J, et al. Serum markers of angiogenesis and myocardial ultrasonic tissue characterization in patients with dilated cardiomyopathy. Eur J Heart Failure 2005; 7: 689-695.
28. Yuda S, Short L, Leano R, Marwick TH. Myocardial abnormalities in hypertensive patients with normal and abnormal left ventricular filling: A study of ultrasound tissue characterization and strain. Clin Sci 2002; 103: 283-293.
29. Naito J, Masuyama T, Mano T, Kondo H, Yamamoto K, Nagano R, et al. Ultrasonic myocardial tissue characterization in patients with dilated cardiomyopathy: Value in noninvasive assessment of myocardial fibrosis. Am Heart J 1996; 131: 115-121.
30. Fujimoto S, Mizuno R, Nakagawa Y, Kimura A, Yamaji K, Yutani C, et al. Ultrasonic tissue characterization in patients with dilated cardiomyopathy: Comparison with findings from right ventricular endomyocardial biopsy. Int J Card Imaging 1999; 15: 391-396.
31. Pan J, Fukuda K, Saito M, Matsuzaki J, Kodama H, Sano M. Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes. Circ Res 1999; 84: 1127-1136.
32. Otani H, Matsuhira S, Akita Y, Kyoi S, Enoki C, Tatsumi K, et al. Role of mechanical stress in the form of cardiomyocyte death during the early phase of reperfusion. Circ J 2006; 70: 1344-1355.
33. Sadoshima J, Xu Y, Slayter HS, Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 1993; 75: 977-984.
34. Yokoyama T, Sekiguchi K, Tanaka T, Tomam K, Arai M, Suzuki T, et al. Angiotensin II and mechanical stretch induce production of tumor necrosis factor in cardiac fibroblasts. Am J Physiol 1999; 276: H1968-H1976.
35. David MD, Bertoglio J, Pierre J. Functional characterization of IL-13 receptor alpha2 gene promoter: A critical role of the transcription factor STAT6 for regulated expression. Oncogene 2003; 22: 3386-3394.
36. Mascareno E, El-Shafei M, Maulik N, Sato M, Guo Y, Das DK, et al. JAK/STAT signaling is associated with cardiac dysfunction during ischemia and reperfusion. Circulation 2001; 104: 325-329.
37. Mascareno E, Dhar M, Siddiqui MA. Signal transduction and activator of transcription (STAT) protein-dependent activation of angiotensinogen promoter: A cellular signal for hypertrophy in cardiac muscle. Proc Natl Acad Sci USA 1998; 95: 5590-5594.